Diagnos Laboratorium Utama Tbk. vs Saratoga Investama Sedaya Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Saratoga Investama Sedaya Tbk. trades at Rp1,675 (market cap 21.98T, 4.38M 24h volume). The key difference: Saratoga Investama Sedaya Tbk. is far larger — about 70.7× Diagnos Laboratorium Utama Tbk.'s market cap, and Saratoga Investama Sedaya Tbk. is more actively traded (4.38M versus 963.6K). Which is the better fit depends on your goals.
| DGNS | SRTG | |
|---|---|---|
Market Cap | 310.75B | 21.98T |
Volume | 963.6K | 4.38M |
Lot | 9.64K | 43.78K |
Turnover | 217.67M | 7.25B |
Average Price | 225.89 | 1,654.99 |
Value | 217.67M | 7.25B |
Indicative Equilibrium Price | 226 | 1,675 |
Indicative Equilibrium Volume | 1K | 1.4K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Saratoga Investama Sedaya Tbk (the Company) was established in Jakarta based on Notarial Deed No. 41 dated May 17, 1991 in conjuction with Notarial Deed No.33 dated July 13 1992, both of Ny. Rukmasanti Hardjasatya, SH., Notary in Jakarta.
Read more on SRTG →